Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nicolini

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Giornale Italiano Di Cardiologia|September 1, 1996
[Heart surgery with cardiopulmonary bypass in patients on chronic dialysis treatment: our experience]R Galli, F Nicolini, C Pace Napoleone, et al.
Bone Marrow Transplantation|July 31, 2001
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patientsO Fitoussi, V Perreau, J M Boiron, et al.
Bone Marrow Transplantation|March 10, 2005
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)A S Michallet, F Nicolini, S Fürst, et al.
The New England Journal of Medicine|July 24, 1997
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study GroupF Guilhot, C Chastang, M Michallet, et al.
Leukemia|October 15, 2005
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinibJ M Cayuela, P Rousselot, F Nicolini, et al.
Leukemia|March 31, 2012
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemiaD Rea, G Etienne, F Nicolini, et al.
Gynecologic Oncology|August 2, 2022
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancerJ I Hoare, H Hockings, J Saxena, et al.
Leukemia|June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemiaC Roche-Lestienne, A Marceau, E Labis, et al.
Journal of Orthopaedic Surgery and Research|November 19, 2025
Segmental range of motion of vertebral body tethering: an in-vitro analysis of single-tether, double-tether, and hybrid constructsMarx Ribeiro, Eduardo A Fancello, Jana Seggewiß, et al.
Leukemia|July 12, 2012
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cellsM Bolzoni, G Donofrio, P Storti, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Giornale Italiano Di Cardiologia|September 1, 1996
[Heart surgery with cardiopulmonary bypass in patients on chronic dialysis treatment: our experience]R Galli, F Nicolini, C Pace Napoleone, et al.
Bone Marrow Transplantation|July 31, 2001
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patientsO Fitoussi, V Perreau, J M Boiron, et al.
Bone Marrow Transplantation|March 10, 2005
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)A S Michallet, F Nicolini, S Fürst, et al.
The New England Journal of Medicine|July 24, 1997
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study GroupF Guilhot, C Chastang, M Michallet, et al.
Leukemia|October 15, 2005
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinibJ M Cayuela, P Rousselot, F Nicolini, et al.
Leukemia|March 31, 2012
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemiaD Rea, G Etienne, F Nicolini, et al.
Gynecologic Oncology|August 2, 2022
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancerJ I Hoare, H Hockings, J Saxena, et al.
Leukemia|June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemiaC Roche-Lestienne, A Marceau, E Labis, et al.
Journal of Orthopaedic Surgery and Research|November 19, 2025
Segmental range of motion of vertebral body tethering: an in-vitro analysis of single-tether, double-tether, and hybrid constructsMarx Ribeiro, Eduardo A Fancello, Jana Seggewiß, et al.
Leukemia|July 12, 2012
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cellsM Bolzoni, G Donofrio, P Storti, et al.
Pageof 5